Company / Current Assets
IRADIMED CORP Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$81.2M
FY2025
5-year range
$75.2M / $81.2M
FY2021-FY2025
Trend
+7.9%
vs FY2024
Sector context
#159 of 160
Health Care
What the data says
Among 160 Health Care companies, IRADIMED CORP is in the bottom 1% for current assets. Current Assets returned to growth in FY2025 after 2 years of decline, reaching $81M.
Based on SEC 10-K filings.
$81M in FY2025 with a 5-year CAGR of +5.0%.
Improved from $76M to $81M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 160This company $81.2M Sector average $5.2B
▼
-98.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.0%, indicating consistent growth.
- In FY2025, current assets increased 7.9% year-over-year.
- Ranks #159 out of 160 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.2M | +7.9% |
| FY2024 | $75.2M | -1.0% |
| FY2023 | $76.0M | -1.9% |
| FY2022 | $77.5M | +1.6% |
| FY2021 | $76.2M | +19.6% |
| FY2020 | $63.7M | +8.1% |
| FY2019 | $59.0M | +32.4% |
| FY2018 | $44.5M | +26.9% |
| FY2017 | $35.1M | +2.7% |
| FY2016 | $34.2M | +0.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026